Related Experiment Video
Updated: Feb 10, 2026

Minimal Erythema Dose MED Testing
Published on: May 28, 2013
Eosinophilic annular erythema treated with dupilumab
Samantha C Gordon1, Sarah N Robinson2, Minawaer Abudu1
1Department of Dermatology, Tufts Medical Center, Boston, MA, USA.
Abstract:
Eosinophilic annular erythema is a rare, benign, recurrent condition characterized by annular skin lesions, tissue eosinophilia, and resistance to a variety of treatments. There are fewer than 30 cases reported in the English literature, 7 of which are in children. We present a case of recurrent eosinophilic annular erythema in an adolescent that was successfully treated with dupilumab, an interleukin-4 receptor alpha antagonist.
Related Concept Videos
Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy
Allergic Reactions
Gene Therapy
Induced Pluripotent Stem Cells
Bacterial Transformation
Griffith made an unexpected discovery when he killed the pathogenic strain and mixed its remains with the live, non-pathogenic strain. Not only did the mixture kill host mice, but it also contained living pathogenic bacteria that...
Metal-Ligand Bonds
In these complexes, transition metals form coordinate covalent bonds, a kind of Lewis acid-base interaction in which both of the electrons in the bond are contributed by a donor (Lewis base) to an electron acceptor (Lewis acid). The Lewis acid in...

